Upgrade to SI Premium - Free Trial

Nomura/Instinet Reiterates Buy Rating on Dr. Reddy\'s Laboratories (DRRD:IN) (RDY)

June 28, 2026 8:24 AM
Nomura/Instinet analyst Saion Mukherjee reiterated a Buy rating and INR1,740.00 price target on Dr. Reddy\'s Laboratories (DRRD:IN) (NYSE: RDY).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Intl Ratings